相关实验视频
Updated: Jun 5, 2025

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.5K
癌症治疗相关心脏功能障碍在乳腺癌患者的发展:一个回顾性研究
Junko Kuroda1, Masayoshi Oikawa2, Emi Tokuda3
1Department of Pharmacy, Fukushima Medical University Hospital, 1 Hikarigaoka, Fukushima, 960‑1295, Japan.
概括
患有高中性粒细胞与淋巴细胞比率 (NLR),晚期癌症或接受多克索鲁比辛治疗的癌症患者患癌症治疗相关心脏功能障碍 (CTRCD) 的风险更高. 早期识别有助于管理这一重大后处理问题.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗环素化疗可以导致与癌症治疗相关的心脏功能障碍 (CTRCD),影响患者的长期健康.
- 识别患有CTRCD高风险的患者对于有效的管理和治疗策略至关重要.
研究的目的:
- 为了确定患有 CTRCD 的高风险的癌症患者的临床特征.
- 改进对抗胰岛素治疗的风险管理方案.
主要方法:
- 一个回顾性,单中心研究,涉及177名乳腺癌患者,接受治疗.
- 在基线和随访点 (3,6,9,12个月) 评估左心室喷射分数 (LVEF),心脏素I (TnI) 和大脑尿素 (BNP).
主要成果:
- 8名患者 (4.5%) 发生了CTRCD.
- 在治疗前的癌症阶段和中性粒细胞与淋巴细胞比率 (NLR) 中,在CTRCD和非CTRCD组之间观察到显著差异.
- 多变量分析表明,治疗前的癌症阶段,NLR和人环素类型 (epirubicin vs. doxorubicin) 是相关因素.
结论:
- 升高的NLR,晚期癌症和多克索鲁比辛的使用是CTRCD的潜在危险因素.
- 患有这些风险因素的患者需要在治疗期间和治疗后加强心血管监测.
相关概念视频
Heart Failure Drugs: Inotropic Agents
517
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
517
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
385
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
385

